NEW YORK (GenomeWeb) – SeraCare and ArcherDx have announced a collaboration to develop and commercialize highly multiplexed RNA fusion reference materials that will be used for validation and quality control of Archer's FusionPlex gene fusion detection kits.

The FusionPlex panels are next generation sequencing-based assay kits that do not require prior knowledge of the breakpoint of fusion partner, but labs have been challenged in finding RNA gene fusion mutations for validation and quality control.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.